Predictors of Reocclusion After Successful Drug-Eluting Stent–Supported Percutaneous Coronary Intervention of Chronic Total Occlusion

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone, Ali A. Rizvi, William Newman et al. · New England Journal of Medicine · 2010 · 896 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

Elvin Kedhi, Kaiyum Sheik Joesoef, Eugène McFadden et al. · The Lancet · 2010 · 687 citations

Medicine, Cardiology, Interventional Cardiology +9

Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience

James A Suero, Steven P. Marso, Philip G. Jones et al. · Journal of the American College of Cardiology · 2001 · 644 citations

Medicine, Cardiology, Surgery +17

A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.

Patrick W. Serruys, P. Ruygrok, Jörg Neuzner et al. · PubMed · 2006 · 348 citations

Medicine, Cardiology, Pharmacotherapy +16